News

Universal newborn screening for congenital cytomegalovirus infection in China could reduce childhood hearing loss cases by 2316 each year, a new study found.

Despite early buzz, remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a failed to reduce mortality, hospital stays.

The VRBPAC committee voted 17-4, with 1 abstention, to support the benefit-risk profile of BNT162b2 for preventing COVID-19 in persons aged 16 years and older.

Many ocular symptoms are associated with the term ‘conjunctivitis’ which may be misleading.

New reports show COVID-19 reinfection is possible, but other data suggest many patients will likely be protected from reinfection for many months, or even years.

Pending investigations of 2 severe adverse events, people with a history of severe allergies are being advised by the UK’s regulatory agency not to get vaccinated.

Even as knowledge about SARS-COV-2 has considerably improved, several aspects remain unknown.

Just one day before the FDA meeting to discuss potential US authorization of the Pfizer and BioNtech vaccine, that country approves the vaccine.

The first COVID-19 vaccines in the US will be from the unique platform. An expert explains how they work.

The announcement follows Pfizer and Moderna who both showed their vaccines to be over 90% efficacious.

TMA mediated by the complement cascade has been identified as a potential cause for severe manifestations of COVID-19 in adults.

Public understanding of adverse events could be an obstacle in the rollout of vaccines to fight the coronavirus disease 2019 (COVID-19).

An overall COVID-19 mortality rate of more than 5% for those admitted to a hospital highlights the urgent need for treatments.

A large-scale diagnosis of SARS-CoV-2 is paramount to downregulating its spread and mitigating the current outbreak.

The primary outcome was to determine how many cases of symptomatic COVID-19 disease there were in participants who had received two doses of the vaccine.

The updated vaccine efficacy and safety outcomes include 37,000-plus participants from the ongoing, multi-national trial.

In the middle of the worst surge the United States has seen as of yet, with over 200000 new cases a day and over 100000 people hospitalized, how do New Yorkers feel about the pandemic?

Antiviral therapy that suppresses HIV-1 viremia does not block release of cell-associated RNA after infection or the inflammatory response it provokes.

The need for rapid, widespread, accurate testing has motivated research exploring new potential strategies.

Investigators identify gene expression which may explain the highly transmissible nature of the virus.

The study was posted to the website clinicaltrials.gov this past Wednesday.

The HIV Policy Lab report examined which countries are adopting laws endorsed by various international agencies in the fight against AIDS.

Authorization for a COVID-19 vaccine in the US appears imminent, bringing with it a host of concerns including the speed of development, inclusivity of clinical trials, safety of mRNA technology, and how to raise levels of trust in vulnerable populations.

Clostridium difficile infection (CDI) was associated with poorer outcomes, including a higher risk of mortality, among patients with chronic pancreatitis, an evaluation of the Nationwide Inpatient Sample database found.

WHO has recently recommended using assessment for monitoring of clinical deterioration in patients with COVID-19.

Previous studies with influenza in animals demonstrated antiviral efficacy was not species restricted.

Tonix Pharmaceuticals is developing a horsepox virus vector vaccine based on a historic platform which was first used for smallpox, and applying it to the world’s most recent virus.

Physicians are beginning to find key patterns which will aid public health in the future.

Genetic sequencing can help assess how patient gut flora compares to donor both before and after FMT, study finds.

Experts call for wide roll-out across West and Central Africa.